AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

CURX · NASDAQ · Biotechnology

Curanex Pharmaceuticals (CURX)

Develops a botanical drug candidate for ulcerative colitis and inflammatory diseases.

$4.43

Pre-market−0.12 (−2.53%)

At close$4.55(+1.11%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions8 holders · as of Mar 31, 2026	1.04%	16.4K shares
Insiders2 holders · as of Sep 2, 2025	45.55%	714.3K shares
Otherremainder	53.41%	837.5K shares

1.57M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (1.57M in the company's Sep 3, 2026 report, 1.42M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Chang LiuInsider10 percent owner	22.99%	360,501	Form 4filed Sep 2, 2025 ↗
Dian Ying Jing¹Insider10 percent owner, officer: Secretary	22.56%	353,808	Form 4filed Sep 2, 2025 ↗
Geode Capital Management, LLCInstitution	0.35%	111,130	13Fas of Mar 31, 2026
Two Sigma Securities, LLCInstitution	0.18%	56,651	13Fas of Mar 31, 2026
XTX Topco LtdInstitution	0.16%	51,289	13Fas of Mar 31, 2026
Citadel Advisors LLCInstitution	0.16%	50,559	13Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution	0.06%	20,254	13Fas of Mar 31, 2026
Citigroup IncInstitution	0.06%	19,332	13Fas of Mar 31, 2026
Jump Financial, LLCInstitution	0.03%	10,551	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.03%	7,995	13Fas of Mar 31, 2026
Jun Liu^2,3Insiderdirector, 10 percent owner, officer: CEO and President	0.00%	0	Form 4filed Sep 2, 2025 ↗

Dian Ying Jing reports a block also reported by Jun Liu; it is counted once, under Jun Liu.
Jun Liu reports a block also reported by Dian Ying Jing; it is counted once, under Dian Ying Jing.
Jun Liu reports a block also reported by Jun Liu; it is counted once, under Jun Liu.

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

8 holders · 327.8K shares · 2 new positions · 4 increased · 4 reduced · 5 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Geode Capital Management, LLC	111.1K	7.09%	+92.5K	May 15, 2026
Two Sigma Securities, LLC	56.7K	3.61%	+56.7K	May 15, 2026
XTX Topco Ltd	51.3K	3.27%	+8.9K	May 15, 2026
Citadel Advisors LLC	50.6K	3.22%	−53.7K	May 15, 2026
Two Sigma Investments, LP	20.3K	1.29%	−40.8K	May 15, 2026
Citigroup Inc	19.3K	1.23%	+19.3Knew	May 11, 2026
Jump Financial, LLC	10.6K	0.67%	−6.9K	May 14, 2026
UBS Group AG	8.0K	0.51%	−5.0K	May 5, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.